Equity

BGF World Healthscience Fund

Overview

Important Information: Capital at Risk. All financial investments involve an element of risk. Therefore, the value of your investment and the income from it will vary and your initial investment amount cannot be guaranteed.
Loading

Performance

Performance

Growth of Hypothetical 10,000

Performance chart data not available for display.
View full chart

Reinvestments

Record Date Ex-Date Payable Date
View full table
  From
30-Sep-2015
To
30-Sep-2016
From
30-Sep-2016
To
30-Sep-2017
From
30-Sep-2017
To
30-Sep-2018
From
30-Sep-2018
To
30-Sep-2019
From
30-Sep-2019
To
30-Sep-2020
Total Return (%)

as of Sep 30, 2020

3.55 6.68 20.05 6.10 11.61
Benchmark (%)

as of Sep 30, 2020

4.62 6.85 16.21 4.59 12.32
  1Y 3Y 5Y 10y Incept.
11.61 12.44 9.45 15.09 7.15
Benchmark (%)

as of Sep 30, 2020

12.32 10.93 8.82 14.81 6.12
  YTD 1m 3M 1Y 3Y 5Y 10y Incept.
2.27 0.49 1.13 11.61 42.16 57.05 307.70 284.32
Benchmark (%)

as of Sep 30, 2020

1.71 0.58 0.36 12.32 36.52 52.62 297.98 218.00
The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance quoted.

Key Facts

Key Facts

Size of Fund (Millions) as of Oct 26, 2020 USD 10,000.891
12m Trailing Yield -
Number of Holdings as of Sep 30, 2020 132
Base Currency U.S. Dollar
Fund Inception Date Apr 6, 2001
Share Class Inception Date Apr 6, 2001
Asset Class Equity
Morningstar Category Sector Equity Healthcare
Benchmark Index MSCI World Health Care Index Net Return in EUR
Domicile Luxembourg
Regulatory Structure UCITS
Management Company BlackRock (Luxembourg) S.A.
Ongoing Charge 2.32%
ISIN LU0171309270
Bloomberg Ticker MERHLEE
Annual Management Fee 2.00%
Initial Charge 3.00%
Performance Fee 0.00%
SEDOL B43GMR3
Bloomberg Benchmark Ticker MSCWRHLEUR
Dealing Settlement Trade Date + 3 days
Dealing Frequency Daily, forward pricing basis
Minimum Initial Investment EUR 5000
Minimum Subsequent Investment -
Use of Income Accumulating

Portfolio Characteristics

Portfolio Characteristics

3y Volatility - Benchmark as of Sep 30, 2020 13.18
3y Beta as of Sep 30, 2020 1.001
5y Volatility - Benchmark as of Sep 30, 2020 12.79
5y Beta as of Sep 30, 2020 1.052

Ratings

Ratings

Morningstar Rating

3
Overall Morningstar Rating for BGF World Healthscience Fund, Class E2, as of Mar 31, 2012 rated against 223 Sector Equity Healthcare Funds.

Risk Indicator

Risk Indicator

1
2
3
4
5
6
7
Low Risk High Risk
Low Yield High Yield

Holdings

Holdings

as of Sep 30, 2020
Name Weight (%)
ABBOTT LABORATORIES 4.98
UNITEDHEALTH GROUP INC 4.87
SANOFI SA 3.91
ROCHE HOLDING PAR AG 3.65
JOHNSON & JOHNSON 3.60
Name Weight (%)
THERMO FISHER SCIENTIFIC INC 2.89
BOSTON SCIENTIFIC CORP 2.69
PFIZER INC 2.46
STRYKER CORP 2.21
AMGEN INC 2.05
Holdings subject to change

Pricing & Exchange

Investor Class Currency Distribution Frequency NAV NAV Amount Change NAV % Change 52wk High 52wk Low Bid Price ISIN Offer Price TIS
E2 EUR Accumulating 42.67 -0.51 -1.18 45.19 33.33 - LU0171309270 - -
X2 USD Accumulating 67.34 -0.95 -1.39 69.78 47.45 - LU0462856898 - -
I2 USD - 12.56 -0.18 -1.41 13.02 8.89 - LU1960219225 - -
C2 USD Accumulating 43.84 -0.63 -1.42 45.48 31.45 - LU0147404148 - -
A2 Hgd EUR Accumulating 12.79 -0.18 -1.39 13.26 9.18 - LU1822774284 - -
A2 Hgd HKD Accumulating 191.14 -2.74 -1.41 198.21 136.00 - LU1061106388 - -
A2 USD Accumulating 55.50 -0.79 -1.40 57.55 39.52 - LU0122379950 - -
E2 USD Accumulating 50.40 -0.72 -1.41 52.27 35.99 - LU0122380701 - -
A2 EUR Accumulating 46.99 -0.57 -1.20 49.59 36.59 - LU0171307068 - -
D2 EUR Accumulating 51.84 -0.62 -1.18 54.43 40.19 - LU0827889485 - -
D2 USD Accumulating 61.22 -0.88 -1.42 63.47 43.41 - LU0329593007 - -
A2 Hgd JPY Accumulating 1,200.00 -17.00 -1.40 1,245.00 859.00 - LU1948809360 - -
Class AI2 EUR - 12.51 -0.15 -1.18 13.20 9.74 - LU1960224654 - -
D4 USD Annual 13.96 -0.20 -1.41 14.47 9.91 - LU1728553774 - -
A2 Hgd CNH Accumulating 158.23 -2.27 -1.41 163.87 111.34 - LU1254117382 - -
A2 Hgd AUD Accumulating 18.78 -0.27 -1.42 19.48 13.45 - LU1023059063 - -
I2 EUR - 10.64 -0.12 -1.12 11.15 8.23 - LU1960219571 - -
A2 Hgd SGD Accumulating 18.95 -0.28 -1.46 19.66 13.56 - LU1057294990 - -
C2 EUR Accumulating 37.12 -0.45 -1.20 39.51 29.12 - LU0331289677 - -

Portfolio Managers

Portfolio Managers

Erin Xie
Head of Health Sciences Investing, Active Equities

Erin Xie, PhD, Managing Director and portfolio manager, is the head of the Health Sciences team, part of BlackRock's Active Equity Group.

Xiang Liu
Xiang Liu
Jeff Lee
Jeff Lee

Literature

Literature